Advertisement

dermwire-tv-logo Created with Sketch.
dermwire-tv-logo Created with Sketch.

Otezla Approved for Plaque Psoriasis

In this week's edition of DermWireTV from the publishers of Practical Dermatology® magazine and DermWire.com, a look at Celgene's Otezla for psoriasis--the first PDE4 inhibitor approved for plaque psoriasis. Plus, Ranbaxy's new dosage strengths of Absorica (isotretinoin), and Galderma's search for projects to support community dermatology.

Advertisement

In This Series

View More

Advertisement